BOARD David Kyle, PhD Chairman and Chief Scientific Officer Dr. David Kyle, Chairman and CSO of Evolve Biosystems Inc, is a 35-year veteran of biotechnology, having co-founded biotech companies in the fields of nutrition and health (including Martek Biosciences, which was acquired in 2011 for $1.1 Billion). At Martek, Dr. Kyle led R&D and Commercial Development for over 15 years through multiple private financings and an IPO in 1993. Martek’s DHA and ARA products are now found in virtually all infant formulas around the world. In 2000 he co-founded the US Chapter of the Mother and Child Foundation, a philanthropic organization headquartered in London, UK, dedicated to preserve and protect the health of pregnant women and their children through better nutrition. In 2013, David joined Evolve BioSystems as employee #2 and has led the Company as Managing Director and then CEO through several private equity financings and finally moving to Chairman of the Board in 2017 when Tim Brown took over as CEO. David combines a distinguished scientific background with significant commercial acumen, has published over 70 scientific articles, edited two books, is the named inventor on over 350 patents, of which over 100 have been issued worldwide, and was inducted into the US Technology Hall of Fame in 2009, for his contributions to Science and Industry. Simon Barnes, PhD, MBA Simon Barnes is a founder and Managing Partner at Circadia Ventures LLP which manages venture capital funds in the field of food sciences and nutrition on behalf of Tate & Lyle the global food ingredients company. He has worked in and around the venture capital industry since 1998 first with Atlas Venture and subsequently with GIMV Venture Capital prior to launching Circadia in 2006. He holds an MA and PhD from the University of Cambridge and an MBA from Imperial College London and has served on numerous boards from early stage to exit in a variety of healthcare and biotechnology sectors. He currently serves on boards in the US, UK and Germany and is a Professor of Practice at Warwick Business School UK. Roger Wyse, PhD Dr. Roger Wyse is Founder & Managing Partner of Spruce Capital Partners. Spruce Capital is a venture capital management company and a leading investor in the agriculture and food sectors. Prior to Spruce he served as President and COO, Venture Capital and Private Equity Funds (Biogreentech), at Burrill & Company. Dr. Wyse has over 40 years of experience as a venture investor, an internationally recognized scientist and as a Dean at two major research universities: Rutgers and the University of Wisconsin-Madison. He currently serves on the board of BIO (Biotechnology Innovation Organization) and the governing boards of its Food & Farm and Industrial & Environmental sections. Gareth Asten, MBA Gareth is a Co-Founder and Managing Partner of Acre Venture Partners, a Santa Monica, CA based venture fund primarily focused on disruptive technologies, products and services for better outcomes in the food system. Prior to founding Acre, Gareth was a key executive team member in three leveraged buyouts, including Bolthouse Farms (sold to the Campbell Soup Company). Gareth holds a BS in Finance from DePaul University and an MBA from Harvard Business School. He is also a Trustee for PS1 Pluralistic Elementary School in Santa Monica, CA, is on the Advisory Board for the Southern California Food Allergy Institute and is a Board Member of Kiss the Ground, a non-profit focused on educating consumers and farmers on the benefits of regenerative farming practices. Patrick Zhang, MBA Patrick Zhang is an investor at Horizons Ventures, where he primarily covers biotechnology and healthcare investments, and manages related portfolio companies for Horizons. He was trained as a chemical engineer and worked in a variety of organizations across industries including power utilities, financial services and investment management. Prior to Horizons, Patrick was an investment banker with Morgan Stanley providing financial advisory services on capital raising and cross-border M&A to his clients. Mr. Zhang received his BS degree in Chemical Engineering from UCLA and MBA from Columbia Business School. Timothy B. Brown, MBA Serving as CEO of Evolve BioSystems, Tim brings over 25 years of experience in the global consumer health, pharma and pediatric nutrition industries, most notably with companies including Mead Johnson Nutrition and Procter & Gamble. Tim has overseen businesses with $1B P&L for over a decade. Following his time as a US Naval officer, Tim was able to launch a range of new, innovative products in the developed and developing world, many of which remain leaders in their respective categories today. CONTACT Evolve BioSystems mailing address: 2121 2nd St., Suite C108 Davis, CA 95618 info@evolvebiosystems.com GET STARTED Home About Science News Resources Careers NEWSLETTER Stay up to date with Evolve. Subscribe SUBSCRIBE © 2019 EVOLVE BIOSYSTEMS. ALL RIGHTS RESERVED. TERMS | PRIVACY POLICY